ITCI Annual Shareholders Equity
$591.42 M
-$64.65 M-9.85%
31 December 2023
Summary:
As of February 1, 2025, ITCI annual stockholders equity is $591.42 million, with the most recent change of -$64.65 million (-9.85%) on December 31, 2023. During the last 3 years, it has fallen by -$65.44 million (-9.96%). ITCI annual shareholders equity is now -9.96% below its all-time high of $656.86 million, reached on December 31, 2020.ITCI Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ITCI Quarterly Shareholders Equity
$1.14 B
+$214.00 K+0.02%
30 September 2024
Summary:
As of February 1, 2025, ITCI quarterly stockholders equity is $1.14 billion, with the most recent change of +$214.00 thousand (+0.02%) on September 30, 2024. Over the past year, it has stayed the same.ITCI quarterly shareholders equity is now at all-time high.ITCI Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ITCI Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.8% | 0.0% |
| 3 y3 years | -10.0% | 0.0% |
| 5 y5 years | +86.2% | 0.0% |
ITCI Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -9.8% | +41.5% | at high | +173.9% |
| 5 y | 5-year | -10.0% | +203.3% | at high | +487.1% |
| alltime | all time | -10.0% | >+9999.0% | at high | >+9999.0% |
Intra-Cellular Therapies Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.14 B(+0.0%) |
| June 2024 | - | $1.14 B(+90.9%) |
| Mar 2024 | - | $599.50 M(+1.4%) |
| Dec 2023 | $591.42 M(-9.9%) | $591.42 M(-1.5%) |
| Sept 2023 | - | $600.68 M(-1.1%) |
| June 2023 | - | $607.09 M(-3.3%) |
| Mar 2023 | - | $627.61 M(-4.3%) |
| Dec 2022 | $656.07 M(+57.0%) | $656.07 M(-4.3%) |
| Sept 2022 | - | $685.42 M(-5.1%) |
| June 2022 | - | $722.20 M(-8.9%) |
| Mar 2022 | - | $792.75 M(+89.7%) |
| Dec 2021 | $417.89 M(-36.4%) | $417.89 M(-14.1%) |
| Sept 2021 | - | $486.76 M(-12.1%) |
| June 2021 | - | $553.59 M(-9.6%) |
| Mar 2021 | - | $612.15 M(-6.8%) |
| Dec 2020 | $656.86 M(+236.8%) | $656.86 M(-7.4%) |
| Sept 2020 | - | $709.40 M(+86.9%) |
| June 2020 | - | $379.53 M(-11.8%) |
| Mar 2020 | - | $430.45 M(+120.7%) |
| Dec 2019 | $195.01 M(-38.6%) | $195.01 M(-14.0%) |
| Sept 2019 | - | $226.88 M(-11.6%) |
| June 2019 | - | $256.77 M(-11.0%) |
| Mar 2019 | - | $288.61 M(-9.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $317.71 M(-30.1%) | $317.71 M(-10.2%) |
| Sept 2018 | - | $353.63 M(-9.4%) |
| June 2018 | - | $390.39 M(-7.8%) |
| Mar 2018 | - | $423.19 M(-6.9%) |
| Dec 2017 | $454.44 M(+21.0%) | $454.44 M(+42.3%) |
| Sept 2017 | - | $319.44 M(-6.0%) |
| June 2017 | - | $339.67 M(-3.8%) |
| Mar 2017 | - | $353.03 M(-6.0%) |
| Dec 2016 | $375.50 M(-21.2%) | $375.50 M(-6.0%) |
| Sept 2016 | - | $399.32 M(-6.3%) |
| June 2016 | - | $425.96 M(-5.9%) |
| Mar 2016 | - | $452.74 M(-4.9%) |
| Dec 2015 | $476.24 M(+295.0%) | $476.24 M(-5.1%) |
| Sept 2015 | - | $501.85 M(+146.5%) |
| June 2015 | - | $203.57 M(-8.5%) |
| Mar 2015 | - | $222.38 M(+84.5%) |
| Dec 2014 | $120.55 M(+281.3%) | $120.55 M(-10.1%) |
| Sept 2014 | - | $134.03 M(-3.3%) |
| June 2014 | - | $138.60 M(-2.9%) |
| Mar 2014 | - | $142.72 M(+351.4%) |
| Dec 2013 | $31.62 M(<-9900.0%) | $31.62 M(-20.1%) |
| Sept 2013 | - | $39.56 M(<-9900.0%) |
| June 2013 | - | -$33.00 K |
| Mar 2013 | -$22.10 K | - |
FAQ
- What is Intra-Cellular Therapies annual stockholders equity?
- What is the all time high annual shareholders equity for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies annual shareholders equity year-on-year change?
- What is Intra-Cellular Therapies quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies quarterly shareholders equity year-on-year change?
What is Intra-Cellular Therapies annual stockholders equity?
The current annual shareholders equity of ITCI is $591.42 M
What is the all time high annual shareholders equity for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high annual stockholders equity is $656.86 M
What is Intra-Cellular Therapies annual shareholders equity year-on-year change?
Over the past year, ITCI annual stockholders equity has changed by -$64.65 M (-9.85%)
What is Intra-Cellular Therapies quarterly stockholders equity?
The current quarterly shareholders equity of ITCI is $1.14 B
What is the all time high quarterly shareholders equity for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high quarterly stockholders equity is $1.14 B
What is Intra-Cellular Therapies quarterly shareholders equity year-on-year change?
Over the past year, ITCI quarterly stockholders equity has changed by $0.00 (0.00%)